bluuebunny/crossref_metadata_2025 huggingface dataset:
Supplemental Table 5 from Genomic Integration of High-Risk HPV Alters Gene Expression in Oropharyngeal Squamous Cell Carcinoma
Authors: Walline Heather M. , Komarck Christine M. , McHugh Jonathan B. , Bellile Emily L. , Brenner J. Chad , Prince Mark E. , McKean Erin L. , Chepeha Douglas B. , Wolf Gregory T. , Worden Francis P. , Bradford Carol R. , Carey Thomas E.
Published: April 2023

Summary of Integration Transcription Analysis in HPV16-Positive Tumors. (F), (R) = Forward or Reverse viral orientation in relation to the cellular gene. Bold text= Viral/cellular fusion transcript, Italicized text=Transcript spans integration site, Grey shade= No transcript produced, a = Nonsense sequence, no alignment, b= Sequence was correct and spliced in frame, c= Sequence mapped to unexpected or rearranged sequences.
Supplementary Figures 1-6 from Cooperative Dynamics of AR and ER Activity in Breast Cancer
Authors: D'Amato Nicholas C. , Gordon Michael A. , Babbs Beatrice , Spoelstra Nicole S. , Carson Butterfield Kiel T. , Torkko Kathleen C. , Phan Vernon T. , Barton Valerie N. , Rogers Thomas J. , Sartorius Carol A. , Elias Anthony , Gertz Jason , Jacobsen Britta M. , Richer Jennifer K.
Published: April 2023

S1. Enza or AR knockdown decrease baseline and E2-induced proliferation of breast cancer cells in vitro. S2. E2 induces and Enza inhibits AR nuclear localization. S3. AR and ER binding in MCF7 cells. S4. Enza synergizes with anti-estrogens. S5. The combination of Enza plus tam reduces ER. S6. PT12 cells are AR+ and Enza alters expression of E2-regulated genes in PT12 xenograft tumors.
Supplementary Figure Legends from Cooperative Dynamics of AR and ER Activity in Breast Cancer
Authors: D'Amato Nicholas C. , Gordon Michael A. , Babbs Beatrice , Spoelstra Nicole S. , Carson Butterfield Kiel T. , Torkko Kathleen C. , Phan Vernon T. , Barton Valerie N. , Rogers Thomas J. , Sartorius Carol A. , Elias Anthony , Gertz Jason , Jacobsen Britta M. , Richer Jennifer K.
Published: April 2023

Supplementary Figure Legends
Supplemental Figure 1 from Genomic Integration of High-Risk HPV Alters Gene Expression in Oropharyngeal Squamous Cell Carcinoma
Authors: Walline Heather M. , Komarck Christine M. , McHugh Jonathan B. , Bellile Emily L. , Brenner J. Chad , Prince Mark E. , McKean Erin L. , Chepeha Douglas B. , Wolf Gregory T. , Worden Francis P. , Bradford Carol R. , Carey Thomas E.
Published: April 2023

Supplemental Figure 1. Representative DIPS PCR and transcript analysis electrophoretic gel images. M=100 bp ladder. Panel A. Representative Responsive Tumor DIPS PCR Gels. Panel B. Representative Recurrent Tumor DIPS PCR Gels. Panel C. Gel Electrophoresis of Tumor Integration Transcript Analysis. Bold text= Viral/cellular fusion transcript, Italicized text=Transcript spans integration site
Supplementary Method and Figure Legend from Tumor Suppressor Activity of Klotho in Breast Cancer Is Revealed by Structure–Function Analysis
Authors: Ligumsky Hagai , Rubinek Tami , Merenbakh-Lamin Keren , Yeheskel Adva , Sertchook Rotem , Shahmoon Shiri , Aviel-Ronen Sarit , Wolf Ido
Published: April 2023

Secretion analysis.
Supplemental Table S5 from Inhibition of S-Adenosylmethionine-Dependent Methyltransferase Attenuates TGFβ1-Induced EMT and Metastasis in Pancreatic Cancer: Putative Roles of miR-663a and miR-4787-5p
Authors: Mody Hardik R. , Hung Sau Wai , AlSaggar Mohammad , Griffin Jazmine , Govindarajan Rajgopal
Published: April 2023

Table S5: List of miRNAs upregulated (fold difference {greater than or equal to}1.5) in MIA PaCa-2 after DZNep.
Supplemental Figure 3 from Calcipotriol Targets LRP6 to Inhibit Wnt Signaling in Pancreatic Cancer
Authors: Arensman Michael D. , Nguyen Phillip , Kershaw Kathleen M. , Lay Anna R. , Ostertag-Hill Claire A. , Sherman Mara H. , Downes Michael , Liddle Christopher , Evans Ronald M. , Dawson David W.
Published: April 2023

Supplemental Figure 3. Calcipotriol reduces VDR message while paradoxically increasing VDR protein levels. (A) VDR expression in AsPC-1 by qPCR after treatments described in Figure 3E. (B) Western blots for VDR or tubulin (loading control) for AsPC-1 lysates at indicated timepoints after calcipotriol treatment. Arrowhead indicates specific band representing VDR protein. qPCR reported as mean {plus minus} SEM. Representative experiments from 2-3 biologic replicates are shown. **P<0.01.
Supplemental File from Inhibition of S-Adenosylmethionine-Dependent Methyltransferase Attenuates TGFβ1-Induced EMT and Metastasis in Pancreatic Cancer: Putative Roles of miR-663a and miR-4787-5p
Authors: Mody Hardik R. , Hung Sau Wai , AlSaggar Mohammad , Griffin Jazmine , Govindarajan Rajgopal
Published: April 2023

1. Supplemental Materials and Methods & Supplemental Figures (Fig. S1-S13) 2. Supplemental Tables (Table S1-S8)
Supplemental Figure 1 from Calcipotriol Targets LRP6 to Inhibit Wnt Signaling in Pancreatic Cancer
Authors: Arensman Michael D. , Nguyen Phillip , Kershaw Kathleen M. , Lay Anna R. , Ostertag-Hill Claire A. , Sherman Mara H. , Downes Michael , Liddle Christopher , Evans Ronald M. , Dawson David W.
Published: April 2023

Supplemental Figure 1. Calcipotriol does not inhibit Wnt signaling through VDR sequestration of β-catenin or induction of DKK1. (A) AsPC-1 cells were treated with 100 nM calcipotriol for 4 hours. Whole cell lysates were collected and immunoprecipitated with anti- β-catenin or isotype control antibodies followed by western blots for β-catenin, E-cadherin or VDR. (B) Western blot for DKK-1 and tubulin (loading control) and (C) BAR reporter activity for indicated conditions. AsPC-1 cells were transfected with control or DKK1 siRNA for 48 hours and treated with vehicle or 100 nM calcipotriol for an additional 24 hours. BAR was normalized to vehicle and siRNA control and is reported as mean {plus minus} SD, with one representative experiment of 3 biological repeats shown.
Supplementary Data from NF-κB–Activated miR-574 Promotes Multiple Malignant and Metastatic Phenotypes by Targeting BNIP3 in Thyroid Carcinoma
Authors: Zhang Zhe-Jia , Xiao Qian , Li Xin-Ying
Published: April 2023

Supplementary figure legends
Table S1 from AKT1E17K Activates Focal Adhesion Kinase and Promotes Melanoma Brain Metastasis
Authors: Kircher David A. , Trombetti Kirby A. , Silvis Mark R. , Parkman Gennie L. , Fischer Grant M. , Angel Stephanie N. , Stehn Christopher M. , Strain Sean C. , Grossmann Allie H. , Duffy Keith L. , Boucher Kenneth M. , McMahon Martin , Davies Michael A. , Mendoza Michelle C. , VanBrocklin Matthew W. , Holmen Sheri L.
Published: April 2023

Supplementary Table 1. Summary of tumor formation in Dct::TVA mice. .
Figure S5 from AKT1E17K Activates Focal Adhesion Kinase and Promotes Melanoma Brain Metastasis
Authors: Kircher David A. , Trombetti Kirby A. , Silvis Mark R. , Parkman Gennie L. , Fischer Grant M. , Angel Stephanie N. , Stehn Christopher M. , Strain Sean C. , Grossmann Allie H. , Duffy Keith L. , Boucher Kenneth M. , McMahon Martin , Davies Michael A. , Mendoza Michelle C. , VanBrocklin Matthew W. , Holmen Sheri L.
Published: April 2023

Supplementary Figure 5. Tumors cluster based on gene expression profile.
Supplementary Figure S1 from Integration of Downstream Signals of Insulin-like Growth Factor-1 Receptor by Endoplasmic Reticulum Stress for Estrogen-Induced Growth or Apoptosis in Breast Cancer Cells
Authors: Fan Ping , Cunliffe Heather E. , Maximov Philipp Y. , Agboke Fadeke A. , McDaniel Russell E. , Zou Xiaojun , Ramos Pilar , Russell Megan L. , Jordan V. Craig
Published: April 2023

The JNK inhibitor arrested cells at G2-phase. (A) MCF-7 cells were cultured in E2-free medium for three days. Then, MCF-7 cells were treated with vehicle (0.1% DMSO) or SP600125 (10-5 mol/L) for 48 hours. Cells were harvested for the analysis of cell cycle. p<0.05, * compared with control. (B) MCF-7:5C cells were treated with vehicle (0.1% DMSO) or SP600125 (10-5 mol/L) for 48 hours. Cells were harvested for the analysis of cell cycle. p<0.05, * compared with control. (C) MCF-7:2A cells were treated with vehicle (0.1% DMSO) or SP600125 (10-5 mol/L) for 48 hours. Cells were harvested for the analysis of cell cycles. p<0.05, * compared with control. (D) The JNK inhibitor completely blocked proliferation induced by E2 in MCF-7 cells. MCF-7 cells were cultured in E2-free medium for three days. Then, MCF-7 cells were treated with vehicle (0.1% DMSO), E2 (10-9 mol/L), SP600125 (10-5 mol/L), and E2 (10-9 mol/L) plus SP600125 (10-5 mol/L). Cells were harvested after 7 days treatment and cell viability was quantitated by determination of total DNA. p<0.05, * compared with control; p<0.001, ** compared with control.
Supplementary Tables S1-S3 from Systematic siRNA Screen Unmasks NSCLC Growth Dependence by Palmitoyltransferase DHHC5
Authors: Tian Hui , Lu Jui-Yun , Shao Chunli , Huffman Kenneth E. , Carstens Ryan M. , Larsen Jill E. , Girard Luc , Liu Hui , Rodriguez-Canales Jaime , Frenkel Eugene P. , Wistuba Ignacio I. , Minna John D. , Hofmann Sandra L.
Published: April 2023

Tables S1-S3 Table S1. Non-small cell lung cancer cell lines used in the current study. Table S2. Clinicopathological characteristics for 194 primary patient samples (NSCLC). Table S3. siRNA used in screen (purchased from Qiagen) in 53 NSCLC lines and 5 HEBCs.
Supplementary Figures S1-S5 and Supplementary Methods from Systematic siRNA Screen Unmasks NSCLC Growth Dependence by Palmitoyltransferase DHHC5
Authors: Tian Hui , Lu Jui-Yun , Shao Chunli , Huffman Kenneth E. , Carstens Ryan M. , Larsen Jill E. , Girard Luc , Liu Hui , Rodriguez-Canales Jaime , Frenkel Eugene P. , Wistuba Ignacio I. , Minna John D. , Hofmann Sandra L.
Published: April 2023

Supplementary Figures S1-S5 and Supplementary Methods. Figure S1: Screening of a large number of NSCLC lines for sensitivity to siRNAs directed against 23 DHHC palmitoyltransferases. Figure S2: Membrane localization of DHHC5 in DHHC5 and DHHS mutant overexpressing cells. Figure S3: Anchorage-independent colony formation (soft agar). Figure S4: DHHC5 immunoblotting (A) and immunohistochemistry (B) of H1299 xenografts developing from H1299 control (CON) or H1299 DHHC5 knockdown cells rescued with a DHHC5-expressing plasmid. Figure S5: DHHC5 immunoblotting (A) and immunohistochemistry (B) of H358 xenografts developing from control (CON) or DHHC5 knockdown (KD) cells.
Supplementary material from Dynamic Epigenetic Regulation by Menin During Pancreatic Islet Tumor Formation
Authors: Lin Wenchu , Watanabe Hideo , Peng Shouyong , Francis Joshua M. , Kaplan Nathan , Pedamallu Chandra Sekhar , Ramachandran Aruna , Agoston Agoston , Bass Adam J. , Meyerson Matthew
Published: April 2023

Supplementary material.
Supplemental Figure S3 from HDAC6 Deacetylates HMGN2 to Regulate Stat5a Activity and Breast Cancer Growth
Authors: Medler Terry R. , Craig Justin M. , Fiorillo Alyson A. , Feeney Yvonne B. , Harrell J. Chuck , Clevenger Charles V.
Published: April 2023

S3. Bufexamac and tubacin inhibit the tumorigenic properties of breast cancer cell in vitro.
Supplementary Figure 1 from VDR Activity Is Differentially Affected by Hic-5 in Prostate Cancer and Stromal Cells
Authors: Solomon Joshua D. , Heitzer Marjet D. , Liu Teresa T. , Beumer Jan H. , Parise Robert A. , Normolle Daniel P. , Leach Damien A. , Buchanan Grant , DeFranco Donald B.
Published: April 2023

PDF file - 10K, Venn Diagram, Microarray Validation.
Supplementary Figure 5 from Aberrant Myosin 1b Expression Promotes Cell Migration and Lymph Node Metastasis of HNSCC
Authors: Ohmura Gaku , Tsujikawa Takahiro , Yaguchi Tomonori , Kawamura Naoshi , Mikami Shuji , Sugiyama Juri , Nakamura Kenta , Kobayashi Asuka , Iwata Takashi , Nakano Hiroshi , Shimada Taketoshi , Hisa Yasuo , Kawakami Yutaka
Published: April 2023

Myo1b knockdown by shRNA in SAS inhibits cell migration.
Supplementary Figure 2 from Aberrant Myosin 1b Expression Promotes Cell Migration and Lymph Node Metastasis of HNSCC
Authors: Ohmura Gaku , Tsujikawa Takahiro , Yaguchi Tomonori , Kawamura Naoshi , Mikami Shuji , Sugiyama Juri , Nakamura Kenta , Kobayashi Asuka , Iwata Takashi , Nakano Hiroshi , Shimada Taketoshi , Hisa Yasuo , Kawakami Yutaka
Published: April 2023

Myo1b is upregulated in cancer tissues of HNSCC.
Supplemental Legends from CD71+ Population Enriched by HPV-E6 Protein Promotes Cancer Aggressiveness and Radioresistance in Cervical Cancer Cells
Authors: Leung Thomas Ho-Yin , Tang Hermit Wai-Man , Siu Michelle Kwan-Yee , Chan David Wai , Chan Karen Kar-Loen , Cheung Annie Nga-Yin , Ngan Hextan Yuen-Sheung
Published: April 2023

Legends of Figure S1, Figure S2 and Figure S3
Supplementary Table S1 from O-GlcNAc Transferase Regulates Cancer Stem–like Potential of Breast Cancer Cells
Authors: Akella Neha M. , Le Minh Giang , Ciraku Lorela , Mukherjee Ayonika , Bacigalupa Zachary A. , Mukhopadhyay Dimpi , Sodi Valerie L. , Reginato Mauricio J.
Published: April 2023

Table S1. List of upregulated and downregulated genes.
Supplementary Table 4 from A YAP/TAZ-Regulated Molecular Signature Is Associated with Oral Squamous Cell Carcinoma
Authors: Hiemer Samantha E. , Zhang Liye , Kartha Vinay K. , Packer Trevor S. , Almershed Munirah , Noonan Vikki , Kukuruzinska Maria , Bais Manish V. , Monti Stefano , Varelas Xaralabos
Published: April 2023

Supplementary Table 4. Microarray data from siCTL, siTAZ, siYAP, and siYAP/TAZ-treated SCC2 cells.
Supplementary Data 4 from miR-122-5p Expression and Secretion in Melanoma Cells Is Amplified by the LPAR3 SH3–Binding Domain to Regulate Wnt1
Authors: Byrnes Charnel C. , Jia Wei , Alshamrani Ali A. , Kuppa Sudeepti S. , Murph Mandi M.
Published: April 2023

Supplementary Figure 4. Comparison of exogenously-added reagents. The qRT-PCR results display the relative abundance of miR-122-5p with no treatment (untreated) versus DharmaFECT alone, miR-122-5p mimic and miR-122-5p antagomir. The latter shows an unexpected increase, precluding its use.
Supplemental Figures 1 and 2 from Sympathetic Signaling Reactivates Quiescent Disseminated Prostate Cancer Cells in the Bone Marrow
Authors: Decker Ann M. , Jung Younghun , Cackowski Frank C. , Yumoto Kenji , Wang Jingchen , Taichman Russel S.
Published: April 2023

Supplemental Figures 1&2
Figure S2 from Tumor Progression Is Mediated by Thymosin-β4 through a TGFβ/MRTF Signaling Axis
Authors: Morita Tsuyoshi , Hayashi Ken'ichiro
Published: April 2023

Figure S2 shows multiple sequence alignment of the promoter regions of mammalian TMSB4X genes.
Supplementary Figure S5 from Global Increase of p16INK4a in APC-Deficient Mouse Liver Drives Clonal Growth of p16INK4a-Negative Tumors
Authors: Ueberham Elke , Glöckner Pia , Göhler Claudia , Straub Beate K. , Teupser Daniel , Schönig Kai , Braeuning Albert , Höhn Anne Kathrin , Jerchow Boris , Birchmeier Walter , Gaunitz Frank , Arendt Thomas , Sansom Owen , Gebhardt Rolf , Ueberham Uwe
Published: April 2023

p16Ink4a mRNA level in distinct tumors.
Supplemental Figure 5 from Genomic cfDNA Analysis of Aqueous Humor in Retinoblastoma Predicts Eye Salvage: The Surrogate Tumor Biopsy for Retinoblastoma
Authors: Berry Jesse L. , Xu Liya , Kooi Irsan , Murphree A. Linn , Prabakar Rishvanth K. , Reid Mark , Stachelek Kevin , Le Bao Han A. , Welter Lisa , Reiser Bibiana J. , Chévez-Barrios Patricia , Jubran Rima , Lee Thomas C. , Kim Jonathan W. , Kuhn Peter , Cobrinik David , Hicks James
Published: April 2023

Supplemental Figure 5, online only: Copy Number Alteration (CNA) profiles from Case 11, 21, and 25 demonstrating change in amplitude of the alterations in longitudinal AH samples taken over time. Case 11 showed a progressive gain of 6p and was eventually enucleated whereas Cases 21 and 25 showed a decrease in the amplitude of alterations and these eyes were salvaged.
Supplemetary Data from Adaptation to HIF1α Deletion in Hypoxic Cancer Cells by Upregulation of GLUT14 and Creatine Metabolism
Authors: Valli Alessandro , Morotti Matteo , Zois Christos E. , Albers Patrick K. , Soga Tomoyoshi , Feldinger Katharina , Fischer Roman , Frejno Martin , McIntyre Alan , Bridges Esther , Haider Syed , Buffa Francesca M. , Baban Dilair , Rodriguez Miguel , Yanes Oscar , Whittington Hannah J. , Lake Hannah A. , Zervou Sevasti , Lygate Craig A. , Kessler Benedikt M. , Harris Adrian L.
Published: April 2023

Supplementary materials and methods
Supplementary Figure 8 from Adaptation to HIF1α Deletion in Hypoxic Cancer Cells by Upregulation of GLUT14 and Creatine Metabolism
Authors: Valli Alessandro , Morotti Matteo , Zois Christos E. , Albers Patrick K. , Soga Tomoyoshi , Feldinger Katharina , Fischer Roman , Frejno Martin , McIntyre Alan , Bridges Esther , Haider Syed , Buffa Francesca M. , Baban Dilair , Rodriguez Miguel , Yanes Oscar , Whittington Hannah J. , Lake Hannah A. , Zervou Sevasti , Lygate Craig A. , Kessler Benedikt M. , Harris Adrian L.
Published: April 2023

S8. Hydrophilic metabolites detection and identification performed by LC/MS QTOF nanoflow using AMRT comparison.
Table S2 from Epigenetic Silencing of THY1 Tracks the Acquisition of the Notch1–EGFR Signaling in a Xenograft Model of CD44+/CD24low/CD90+ Myoepithelial Cells
Authors: Montanari Micaela , Carbone Maria Rita , Coppola Luigi , Giuliano Mario , Arpino Grazia , Lauria Rossella , Nardone Agostina , Leccia Felicia , Trivedi Meghana V. , Garbi Corrado , Bianco Roberto , Avvedimento Enrico V. , De Placido Sabino , Veneziani Bianca Maria
Published: April 2023

List of primers
Figure S1, B-D from Diffuse Intrinsic Pontine Glioma Cells Are Vulnerable to Mitotic Abnormalities Associated with BMI-1 Modulation
Authors: Senthil Kumar Shiva , Sengupta Satarupa , Zhu Xiaoting , Mishra Deepak Kumar , Phoenix Timothy , Dyer Lisa , Fuller Christine , Stevenson Charles B. , DeWire Mariko , Fouladi Maryam , Drissi Rachid
Published: April 2023

B, tSNE plot of scRNAseq data from the Filbin-Cohort representing correlations between different samples and C, relative BMI-1 expression. D, Correlation of Bmi-1 expression and stemness score in murine DIPG tumor and control brain stem.
Table S4 from T-Cell Deletion of MyD88 Connects IL17 and IκBζ to RAS Oncogenesis
Authors: Cataisson Christophe , Salcedo Rosalba , Michalowski Aleksandra M. , Klosterman Mary , Naik Shruti , Li Luowei , Pan Michelle J. , Sweet Amalia , Chen Jin-Qiu , Kostecka Laurie G. , Karwan Megan , Smith Loretta , Dai Ren-Ming , Stewart C. Andrew , Lyakh Lyudmila , Hsieh Wang-Ting , Khan Asra , Yang Howard , Lee Maxwell , Trinchieri Giorgio , Yuspa Stuart H.
Published: April 2023

Supplemental table 4: GSEA estimates underlying data presented in figure 6B and 6C.
Inhibition of DNA methylation induces p16 de-repression from Histone H3.3K27M Represses p16 to Accelerate Gliomagenesis in a Murine Model of DIPG
Authors: Cordero Francisco J. , Huang Zhiqing , Grenier Carole , He Xingyao , Hu Guo , McLendon Roger E. , Murphy Susan K. , Hashizume Rintaro , Becher Oren J.
Published: April 2023

A. ChIP-qPCR on H3.3K27M-GFP, and H3.3WT-GFP (n=3 each) expressing murine tumor lines for DNMT1 localization to p16 promoter region. B. Pyrosequencing analysis of DNA methylation at the p16 promoter after 7days of 1uM GSK343 treatment (n=3 for both groups). C. Pyrosequencing DNA methylation analysis of p16 and p19 promoters on human DIPG lines (SF8628, DIPG IV, and DIPG 007) treated with 72hr decitabine or vehicle at 10uM (*= p< 0.05, n=3). D. Western blot analysis of human DIPG lines treated with 72hr decitabine or vehicle and blotted for p16 (n=2) E. BrdU incorporation IC50 analysis of decitabine and azacitidine DNA methyltransferase inhibitors on mouse tumor cells (top 2 panels). Decitabine IC50 on human DIPG lines (bottom 3 panels). IC50''s for human lines were as follows: SF6828 (8μM), (0.5μM), DIPG IV, and DIPG 007 (2μM).
Supplemental Figure Legend from Role of Rac1 Pathway in Epithelial-to-Mesenchymal Transition and Cancer Stem-like Cell Phenotypes in Gastric Adenocarcinoma
Authors: Yoon Changhwan , Cho Soo-Jeong , Chang Kevin K. , Park Do Joong , Ryeom Sandra W. , Yoon Sam S.
Published: April 2023

Supplemental Figure Legend.
Figure S5 from PPARδ Reprograms Glutamine Metabolism in Sorafenib-Resistant HCC
Authors: Kim Mi-Jin , Choi Yeon-Kyung , Park Soo Young , Jang Se Young , Lee Jung Yi , Ham Hye Jin , Kim Byung-Gyu , Jeon Hui-Jeon , Kim Ji-Hyun , Kim Jung-Guk , Lee In-Kyu , Park Keun-Gyu
Published: April 2023

Figure S5 shows Effect of a PPARÎ' inhibitor on tumor growth in xenograft model.
Figure S2 from PPARδ Reprograms Glutamine Metabolism in Sorafenib-Resistant HCC
Authors: Kim Mi-Jin , Choi Yeon-Kyung , Park Soo Young , Jang Se Young , Lee Jung Yi , Ham Hye Jin , Kim Byung-Gyu , Jeon Hui-Jeon , Kim Ji-Hyun , Kim Jung-Guk , Lee In-Kyu , Park Keun-Gyu
Published: April 2023

Figure S2 shows relative amount of intracellular glutamine level and abundance of indicated protein levels in sorafenib-sensitive and -resistant HCC cells.
Supplementary Figure S2 from Estrogen-Induced Apoptosis in Breast Cancers Is Phenocopied by Blocking Dephosphorylation of Eukaryotic Initiation Factor 2 Alpha (eIF2α) Protein
Authors: Sengupta Surojeet , Sevigny Catherine M. , Bhattacharya Poulomi , Jordan V. Craig , Clarke Robert
Published: April 2023

Effect of 17β-estradiol (E2), 4-hydroxytamoxifen (4OHT), Fulvestratnt (Ful), and its combination on LCC9, T47D:A18 and T47D:A18/4-OHT cells.
Figure S1 from Targeted Next-Generation Sequencing for Detecting MLL Gene Fusions in Leukemia
Authors: Afrin Sadia , Zhang Christine R.C. , Meyer Claus , Stinson Caedyn L. , Pham Thy , Bruxner Timothy J.C. , Venn Nicola C. , Trahair Toby N. , Sutton Rosemary , Marschalek Rolf , Fink J. Lynn , Moore Andrew S.
Published: April 2023

Expression of the exon 10 fusion transcript in patient 17 and patient 32. Standard curve was established using patient 32 sample in a range from 25ng/µl to 0.1 ng/µl in 1 in 2 serial dilutions.
Supplementary table 4 from Blockade of AP-1 Potentiates Endocrine Therapy and Overcomes Resistance
Authors: Malorni Luca , Giuliano Mario , Migliaccio Ilenia , Wang Tao , Creighton Chad J. , Lupien Mathieu , Fu Xiaoyong , Hilsenbeck Susan G. , Healy Nuala , De Angelis Carmine , Mazumdar Abhijit , Trivedi Meghana V. , Massarweh Suleiman , Gutierrez Carolina , De Placido Sabino , Jeselsohn Rinath , Brown Myles , Brown Powel H. , Osborne C. Kent , Schiff Rachel
Published: April 2023

Time to progression with E2 and Tam +/- Dox in xenografts of MCF7 Tet-off Vector control clone 3.
Supplementary table 2 from Blockade of AP-1 Potentiates Endocrine Therapy and Overcomes Resistance
Authors: Malorni Luca , Giuliano Mario , Migliaccio Ilenia , Wang Tao , Creighton Chad J. , Lupien Mathieu , Fu Xiaoyong , Hilsenbeck Susan G. , Healy Nuala , De Angelis Carmine , Mazumdar Abhijit , Trivedi Meghana V. , Massarweh Suleiman , Gutierrez Carolina , De Placido Sabino , Jeselsohn Rinath , Brown Myles , Brown Powel H. , Osborne C. Kent , Schiff Rachel
Published: April 2023

Genes down-regulated in Tam-R and putatively associated with EGF-induced ER binding sites (genes containing an AP-1 motif are shown in bold)
Supplementary Figure 2 from Blockade of AP-1 Potentiates Endocrine Therapy and Overcomes Resistance
Authors: Malorni Luca , Giuliano Mario , Migliaccio Ilenia , Wang Tao , Creighton Chad J. , Lupien Mathieu , Fu Xiaoyong , Hilsenbeck Susan G. , Healy Nuala , De Angelis Carmine , Mazumdar Abhijit , Trivedi Meghana V. , Massarweh Suleiman , Gutierrez Carolina , De Placido Sabino , Jeselsohn Rinath , Brown Myles , Brown Powel H. , Osborne C. Kent , Schiff Rachel
Published: April 2023

Full gel
Figure S3 from Molecular Signature and Mechanisms of Hepatitis D Virus–Associated Hepatocellular Carcinoma
Authors: Diaz Giacomo , Engle Ronald E. , Tice Ashley , Melis Marta , Montenegro Stephanie , Rodriguez-Canales Jaime , Hanson Jeffrey , Emmert-Buck Michael R. , Bock Kevin W. , Moore Ian N. , Zamboni Fausto , Govindarajan Sugantha , Kleiner David E. , Farci Patrizia
Published: April 2023

Synopsis of the 20 top-scored pathways associated with genes identified in malignant hepatocytes derived from HDV-, HBV- and HCV-HCC.
Figure S1-S5 from Modulation of Mutant KrasG12D-Driven Lung Tumorigenesis In Vivo by Gain or Loss of PCDH7 Function
Authors: Zhou Xiaorong , Padanad Mahesh S. , Evers Bret M. , Smith Bethany , Novaresi Nicole , Suresh Shruthy , Richardson James A. , Stein Emily , Zhu Jingfei , Hammer Robert E. , O'Donnell Kathryn A.
Published: April 2023

S1. Generation of PCDH7LSL mice and analysis of lung tumors in vivo. S2. TUNEL staining of lung tumors. S3. Validation of CRISPR/Cas9-editing of Pcdh7. S4. Diminished invasiveness in Pcdh7 depleted KP tumors. S5. Sequences of gene-edited alleles in KP tumors.
Supplemental Table 1 from B-cell Receptor Signaling Regulates Metabolism in Chronic Lymphocytic Leukemia
Authors: Vangapandu Hima V. , Havranek Ondrej , Ayres Mary L. , Kaipparettu Benny Abraham , Balakrishnan Kumudha , Wierda William G. , Keating Michael J. , Davis R. Eric , Stellrecht Christine M. , Gandhi Varsha
Published: April 2023

Supplemental Table 1 showing patient characteristics.
Supplementary Table S2 from Intron 1–Mediated Regulation of EGFR Expression in EGFR-Dependent Malignancies Is Mediated by AP-1 and BET Proteins
Authors: Jameson Nathan M. , Ma Jianhui , Benitez Jorge , Izurieta Alejandro , Han Jee Yun , Mendez Robert , Parisian Alison , Furnari Frank
Published: April 2023

Primer and gRNA sequences
Table S2 from The Landscape of Isoform Switches in Human Cancers
Authors: Vitting-Seerup Kristoffer , Sandelin Albin
Published: April 2023

List of isoform switches with predicted consequences.
Table S3 from Discrete Adaptive Responses to MEK Inhibitor in Subpopulations of Triple-Negative Breast Cancer
Authors: Goulet Daniel R. , Foster Joseph P. , Zawistowski Jon S. , Bevill Samantha M. , Noël Mélodie P. , Olivares-Quintero José F. , Sciaky Noah , Singh Darshan , Santos Charlene , Pattenden Samantha G. , Davis Ian J. , Johnson Gary L.
Published: April 2023

Karyotyping Results
Figure S4 from Discrete Adaptive Responses to MEK Inhibitor in Subpopulations of Triple-Negative Breast Cancer
Authors: Goulet Daniel R. , Foster Joseph P. , Zawistowski Jon S. , Bevill Samantha M. , Noël Mélodie P. , Olivares-Quintero José F. , Sciaky Noah , Singh Darshan , Santos Charlene , Pattenden Samantha G. , Davis Ian J. , Johnson Gary L.
Published: April 2023

Drug Resistant POS Cells Emerge Following Chronic Trametinib Treatment.
Figure S2 from CREBBP/EP300 Bromodomain Inhibition Affects the Proliferation of AR-Positive Breast Cancer Cell Lines
Authors: Garcia-Carpizo Veronica , Ruiz-Llorente Sergio , Sarmentero Jacinto , González-Corpas Ana , Barrero Maria J.
Published: April 2023

Changes in gene expression caused by the treatments. (a) Log2 of fold change to DMSO of all genes after treatment of the indicated cell lines with 150nM JQ1 or 2μM CBP30 for 48 hours (b) Overlap of downregulated and upregulated genes (FDR<0.05) by each treatment in each cell line. P-values for the overlap determined using a hypergeometric test are shown.
Figure S1, Figure S2, Figure S3, Figure S4 from The Hypoxic Tumor Microenvironment Promotes Invadopodia Formation and Metastasis through LPA1 Receptor and EGFR Cooperation
Authors: Harper Kelly , R. Lavoie Roxane , Charbonneau Martine , Brochu-Gaudreau Karine , Dubois Claire M.
Published: April 2023

Figure S1 shows qPCR assessment of LPA receptors knockdown Figure S2 shows EGFR transactivation by LPA1 in various cell lines. Figure S3 shows qPCR assessment of EGFR knockdown in HT1080 cells. Figure S4 shows that Src inhibition blocks EGFR phosphorylation in hypoxic HT1080 cells.
Figure S5 from Targeting USP22 Suppresses Tumorigenicity and Enhances Cisplatin Sensitivity Through ALDH1A3 Downregulation in Cancer-Initiating Cells from Lung Adenocarcinoma
Authors: Yun Xinwei , Zhang Keqiang , Wang Jinhui , Pangeni Rajendra P. , Yang Lu , Bonner Melissa , Wu Jun , Wang Jami , Nardi Isaac K. , Gao Ming , Raz Dan J.
Published: April 2023

Correlation between the levels of CD133 (PROM1) mRNA with that of ALDH1A3 mRNA in lung adenocarcinoma tissues from TCGA portal
Figure S3 from Targeting USP22 Suppresses Tumorigenicity and Enhances Cisplatin Sensitivity Through ALDH1A3 Downregulation in Cancer-Initiating Cells from Lung Adenocarcinoma
Authors: Yun Xinwei , Zhang Keqiang , Wang Jinhui , Pangeni Rajendra P. , Yang Lu , Bonner Melissa , Wu Jun , Wang Jami , Nardi Isaac K. , Gao Ming , Raz Dan J.
Published: April 2023

Knockdown of USP22 in A549, H1299, and H838 lung cancer cells significantly down-regulated ALDH1A3 mRNA expression in these cells
Figure S2 from Targeting USP22 Suppresses Tumorigenicity and Enhances Cisplatin Sensitivity Through ALDH1A3 Downregulation in Cancer-Initiating Cells from Lung Adenocarcinoma
Authors: Yun Xinwei , Zhang Keqiang , Wang Jinhui , Pangeni Rajendra P. , Yang Lu , Bonner Melissa , Wu Jun , Wang Jami , Nardi Isaac K. , Gao Ming , Raz Dan J.
Published: April 2023

USP22 knockdown with another USP22-shRNA
Supplemental Table 3 from Elevated V–ATPase Activity Following PTEN Loss Is Required for Enhanced Oncogenic Signaling in Breast Cancer
Authors: Mohammad Amro H. , Kim Sung-Hoon , Bertos Nicholas , El-Assaad Wissal , Nandi Ipshita , Smith Harvey , Yang Jieyi , Chen Owen J. , Gamache Isabelle , Rao Trisha , Gagnon Bruno , Gruosso Tina , Tremblay Michel L. , Sonenberg Nahum , Guiot Marie-Christine , Muller William , Park Morag , Teodoro Jose G.
Published: April 2023

Sequence of qPCR, siRNA, and shRNA used
Figure S1 from Targeting USP22 Suppresses Tumorigenicity and Enhances Cisplatin Sensitivity Through ALDH1A3 Downregulation in Cancer-Initiating Cells from Lung Adenocarcinoma
Authors: Yun Xinwei , Zhang Keqiang , Wang Jinhui , Pangeni Rajendra P. , Yang Lu , Bonner Melissa , Wu Jun , Wang Jami , Nardi Isaac K. , Gao Ming , Raz Dan J.
Published: April 2023

Immunofluorescence of CD133 and USP22/H2Bub1
Supplementary Figure S2 from The mTOR Targets 4E-BP1/2 Restrain Tumor Growth and Promote Hypoxia Tolerance in PTEN-driven Prostate Cancer
Authors: Ding Mei , Van der Kwast Theodorus H. , Vellanki Ravi N. , Foltz Warren D. , McKee Trevor D. , Sonenberg Nahum , Pandolfi Pier P. , Koritzinsky Marianne , Wouters Bradly G.
Published: April 2023

Histological examination of prostates from mouse cohorts.
Figure S2 from BRCA1-Interacting Protein OLA1 Requires Interaction with BARD1 to Regulate Centrosome Number
Authors: Yoshino Yuki , Qi Huicheng , Fujita Hiroki , Shirota Matsuyuki , Abe Shun , Komiyama Yuhei , Shindo Kazuha , Nakayama Masahiro , Matsuzawa Ayako , Kobayashi Akihiro , Ogoh Honami , Watanabe Toshio , Ishioka Chikashi , Chiba Natsuko
Published: April 2023

Knockdown of OLA1 did not cause centrosome amplification in non-mammary tissue-derived cell lines.
Supplementary Data S18 from A Unique Morphological Phenotype in Chemoresistant Triple-Negative Breast Cancer Reveals Metabolic Reprogramming and PLIN4 Expression as a Molecular Vulnerability
Authors: Sirois Isabelle , Aguilar-Mahecha Adriana , Lafleur Josiane , Fowler Emma , Vu Viet , Scriver Michelle , Buchanan Marguerite , Chabot Catherine , Ramanathan Aparna , Balachandran Banujan , Légaré Stéphanie , Przybytkowski Ewa , Lan Cathy , Krzemien Urszula , Cavallone Luca , Aleynikova Olga , Ferrario Cristiano , Guilbert Marie-Christine , Benlimame Naciba , Saad Amine , Alaoui-Jamali Moulay , Saragovi Horace Uri , Josephy Sylvia , O'Flanagan Ciara , Hursting Stephen D. , Richard Vincent R. , Zahedi René P. , Borchers Christoph H. , Bareke Eric , Nabavi Sheida , Tonellato Peter , Roy Josée-Anne , Robidoux André , Marcus Elizabeth A. , Mihalcioiu Catalin , Majewski Jacek , Basik Mark
Published: April 2023

Table S18: Two-way ANOVA
Figure S3 from PKCϵ Controls Mitotic Progression by Regulating Centrosome Migration and Mitotic Spindle Assembly
Authors: Martini Silvia , Soliman Tanya , Gobbi Giuliana , Mirandola Prisco , Carubbi Cecilia , Masselli Elena , Pozzi Giulia , Parker Peter J. , Vitale Marco
Published: April 2023

Figure S3. PKCe, p150 (Glued) and Dynein cargo-BubR1 localization upon PKCe or Dynein inhibition.
Figure S1 from PKCϵ Controls Mitotic Progression by Regulating Centrosome Migration and Mitotic Spindle Assembly
Authors: Martini Silvia , Soliman Tanya , Gobbi Giuliana , Mirandola Prisco , Carubbi Cecilia , Masselli Elena , Pozzi Giulia , Parker Peter J. , Vitale Marco
Published: April 2023

This Figure shows the specificity of the two siRNAs used and the PKCepsilon inhibition affects mitotic spindle morphology resulting in a higher number of cells unable to complete mitosis.
Supplementary Figure 3 from Epigenetic Regulation of ZBTB18 Promotes Glioblastoma Progression
Authors: Fedele Vita , Dai Fangping , Masilamani Anie P. , Heiland Dieter H. , Kling Eva , Gätjens-Sanchez Ana M. , Ferrarese Roberto , Platania Leonardo , Doostkam Soroush , Kim Hyunsoo , Nelander Sven , Weyerbrock Astrid , Prinz Marco , Califano Andrea , Iavarone Antonio , Bredel Markus , Carro Maria S.
Published: April 2023

GSEA analysis in JX6.
Supplementary Figures from A First-in-Class TWIST1 Inhibitor with Activity in Oncogene-Driven Lung Cancer
Authors: Yochum Zachary A. , Cades Jessica , Mazzacurati Lucia , Neumann Neil M. , Khetarpal Susheel K. , Chatterjee Suman , Wang Hailun , Attar Myriam A. , Huang Eric H.-B. , Chatley Sarah N. , Nugent Katriana , Somasundaram Ashwin , Engh Johnathan A. , Ewald Andrew J. , Cho Yoon-Jae , Rudin Charles M. , Tran Phuoc T. , Burns Timothy F.
Published: April 2023

Supplementary Figure 1: FGF2 treatment induces branching morphogenesis of primary epithelial cells in 3D culture. Supplementary Figure 2: Basal Expression Levels of TWIST1 in KRAS mutant and MET Amplified/Mutant NSCLC Cell Lines. Supplementary Figure 3: Harmine treatment induces Oncogene-Induced Senescence (OIS) in EGFR and MET-mutant NSCLC cell lines. Supplementary Figure 4: Harmine induces apoptosis in oncogene-driven NSCLC cell lines. Supplementary Figure 5: Harmine treatment promotes TWIST1 degradation and decreases TWIST1 protein stability. Supplementary Figure 6: Silencing of E2A induces apoptosis and phenocopies silencing of TWIST1. Supplementary Figure 7: Overexpression of TWIST1 or its binding partner, E2A, rescues harmine induced growth inhibition. Supplementary Figure 8: Treatment with harmine decreases tumor growth in a KRAS mutant Patient-Derived Xenograph (PDX) model and degrades Twist1 and induces apoptosis in transgenic mouse model of Kras mutant lung cancer. Supplementary Table 1: Rank list of compounds from Connectivity mapping (CMAP) analysis Supplementary Table 2: List of primers used for qRT-PCR Supplementary Table 3: List of primers used for Taqman qRT-PCR Supplementary Table 4: List of antibodies used in current study Supplementary Table 5: Sequences for TWIST1/TCF3 shRNA (5â€™ â€" 3â€™) in pKLO.1 Supplementary Table 6: ORFs obtained from Johns Hopkins University HiT Center Supplementary Table 7: Source of Plasmids utilized
Supplementary Data from A First-in-Class TWIST1 Inhibitor with Activity in Oncogene-Driven Lung Cancer
Authors: Yochum Zachary A. , Cades Jessica , Mazzacurati Lucia , Neumann Neil M. , Khetarpal Susheel K. , Chatterjee Suman , Wang Hailun , Attar Myriam A. , Huang Eric H.-B. , Chatley Sarah N. , Nugent Katriana , Somasundaram Ashwin , Engh Johnathan A. , Ewald Andrew J. , Cho Yoon-Jae , Rudin Charles M. , Tran Phuoc T. , Burns Timothy F.
Published: April 2023

Supplementary Figure legends and methods
Supplemental Figures from Loss of MAP3K7 Sensitizes Prostate Cancer Cells to CDK1/2 Inhibition and DNA Damage by Disrupting Homologous Recombination
Authors: Washino Satoshi , Rider Leah C. , Romero Lina , Jillson Lauren K. , Affandi Trisiani , Ohm Angela M. , Lam Elaine T. , Reyland Mary E. , Costello James C. , Cramer Scott D.
Published: April 2023

The supplemental figures provide supporting data including controls, synergism studies, dose response curves, validation of knockdown, etc.
Supplementary Table 2 from A Minimal DNA Methylation Signature in Oral Tongue Squamous Cell Carcinoma Links Altered Methylation with Tumor Attributes
Authors: Krishnan Neeraja M. , Dhas Kunal , Nair Jayalakshmi , Palve Vinayak , Bagwan Jamir , Siddappa Gangotri , Suresh Amritha , Kekatpure Vikram D. , Kuriakose Moni Abraham , Panda Binay
Published: April 2023

List of ambiguously mapped probe indices and the number of multiply mapped positions in hg19 reference.
Figure S1 from Radiation-Induced Myofibroblasts Promote Tumor Growth via Mitochondrial ROS–Activated TGFβ Signaling
Authors: Shimura Tsutomu , Sasatani Megumi , Kawai Hidehiko , Kamiya Kenji , Kobayashi Junya , Komatsu Kenshi , Kunugita Naoki
Published: April 2023

Induction of alpha-SMA after acute single radiation
Supplementary figure legends from AHNAK Loss in Mice Promotes Type II Pneumocyte Hyperplasia and Lung Tumor Development
Authors: Park Jun Won , Kim Il Yong , Choi Ji Won , Lim Hee Jung , Shin Jae Hoon , Kim Yo Na , Lee Seo Hyun , Son Yeri , Sohn Mira , Woo Jong Kyu , Jeong Joseph H. , Lee Cheolju , Bae Yun Soo , Seong Je Kyung
Published: April 2023

Supplementary figure legends
Figure S5 from IKKβ-Mediated Resistance to Skin Cancer Development Is Ink4a/Arf-Dependent
Authors: Page Angustias , Bravo Ana , Suarez-Cabrera Cristian , Alameda Josefa P. , Casanova M. Llanos , Lorz Corina , Segrelles Carmen , Segovia José C. , Paramio Jesús M. , Navarro Manuel , Ramirez Angel
Published: April 2023

Study of SCCs in Ink4a/ArfKO background.
Figure S4 from IKKβ-Mediated Resistance to Skin Cancer Development Is Ink4a/Arf-Dependent
Authors: Page Angustias , Bravo Ana , Suarez-Cabrera Cristian , Alameda Josefa P. , Casanova M. Llanos , Lorz Corina , Segrelles Carmen , Segovia José C. , Paramio Jesús M. , Navarro Manuel , Ramirez Angel
Published: April 2023

Tumor multiplicity, histopathological charecterization and size distribution in Ink4a/Arfwt/wt and Ink4a/Arfwt/wt/K5-IKKbeta mice.
Table S1 from Normal and Cancerous Tissues Release Extrachromosomal Circular DNA (eccDNA) into the Circulation
Authors: Kumar Pankaj , Dillon Laura W. , Shibata Yoshiyuki , Jazaeri Amir A. , Jones David R. , Dutta Anindya
Published: April 2023

Table S1: Length and GC content of plasma microDNA isolated from healthy volunteers.
Figure S5 from De Novo Fatty Acid Synthesis-Driven Sphingolipid Metabolism Promotes Metastatic Potential of Colorectal Cancer
Authors: Jafari Naser , Drury James , Morris Andrew J. , Onono Fredrick O. , Stevens Payton D. , Gao Tianyan , Liu Jinpeng , Wang Chi , Lee Eun Y. , Weiss Heidi L. , Evers B. Mark , Zaytseva Yekaterina Y.
Published: April 2023

Supplemental Figure 5. S1P treatment rescues the effect of TVB-3664 on inhibition of signaling pathway associated with cell migration and invasion.
Figure S2 from De Novo Fatty Acid Synthesis-Driven Sphingolipid Metabolism Promotes Metastatic Potential of Colorectal Cancer
Authors: Jafari Naser , Drury James , Morris Andrew J. , Onono Fredrick O. , Stevens Payton D. , Gao Tianyan , Liu Jinpeng , Wang Chi , Lee Eun Y. , Weiss Heidi L. , Evers B. Mark , Zaytseva Yekaterina Y.
Published: April 2023

Supplemental Figure 2. Inhibition of FASN and sphingolipid metabolism limits formation of focal adhesion complexes in primary CRC cells.
Table S5, S6, S7 from Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate
Authors: Elfandy Habiba , Armenia Joshua , Pederzoli Filippo , Pullman Eli , Pertega-Gomes Nelma , Schultz Nikolaus , Viswanathan Kartik , Vosoughi Aram , Blattner Mirjam , Stopsack Konrad H. , Zadra Giorgia , Penney Kathryn L. , Mosquera Juan Miguel , Tyekucheva Svitlana , Mucci Lorelei A. , Barbieri Christopher , Loda Massimo
Published: April 2023

Table S5: Top-ranked mutation events in Cribriform Carcinoma (ICC), arranged by p-values; Table S6: Overexpressed and underexpressed genes in Cribriform Carcinoma (ICC); Table 7: Upregulated and down regulated gene sets and pathways in cribriform carcinoma (ICC).
Supplementary Data 3 from Abemaciclib Is Effective Against Pancreatic Cancer Cells and Synergizes with HuR and YAP1 Inhibition
Authors: Dhir Teena , Schultz Christopher W. , Jain Aditi , Brown Samantha Z. , Haber Alex , Goetz Austin , Xi Chunhua , Su Gloria H. , Xu Liang , Posey James , Jiang Wei , Yeo Charles J. , Golan Talia , Pishvaian Michael J. , Brody Jonathan R.
Published: April 2023

Supplemental figure 3: (A) Quantification of total β-galactosidase positive counts over total cells present, for H2O2 treated cells and no treatment cells. Cells were either treated constantly with H2O2 at 10µM or 100µM, or two hours prior to collection untreated cells were treated with 500µM H2O2 (pulse). (B) DCFDA assay to detect ROS levels performed on cells treated with H2O2 or abemaciclib over 7 days and collected and quantified daily. (C) Quantification of total β-galactosidase positive counts over total cells present for Mia PaCa2 cells, treated with various chemotherapeutics at indicated concentration, and compared to no treatment over days 1-5. (D) qPCR primer sequences for SASP markers as listed.
Supplementary Data 2 from Abemaciclib Is Effective Against Pancreatic Cancer Cells and Synergizes with HuR and YAP1 Inhibition
Authors: Dhir Teena , Schultz Christopher W. , Jain Aditi , Brown Samantha Z. , Haber Alex , Goetz Austin , Xi Chunhua , Su Gloria H. , Xu Liang , Posey James , Jiang Wei , Yeo Charles J. , Golan Talia , Pishvaian Michael J. , Brody Jonathan R.
Published: April 2023

Supplemental figure 2: (A) Annexin V flow cytometry cellular gating for cells treated with abemaciclib and shown as dot/ contour plots. Gating was done using unlabeled and single labeled positive control cells.
Figure S5 from Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate
Authors: Elfandy Habiba , Armenia Joshua , Pederzoli Filippo , Pullman Eli , Pertega-Gomes Nelma , Schultz Nikolaus , Viswanathan Kartik , Vosoughi Aram , Blattner Mirjam , Stopsack Konrad H. , Zadra Giorgia , Penney Kathryn L. , Mosquera Juan Miguel , Tyekucheva Svitlana , Mucci Lorelei A. , Barbieri Christopher , Loda Massimo
Published: April 2023

Difference in FGA between Cribriform Carcinoma (ICC) and Noncribriform Carcinoma (NC4) as well as between Gleason scores.
Figure S2 from Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate
Authors: Elfandy Habiba , Armenia Joshua , Pederzoli Filippo , Pullman Eli , Pertega-Gomes Nelma , Schultz Nikolaus , Viswanathan Kartik , Vosoughi Aram , Blattner Mirjam , Stopsack Konrad H. , Zadra Giorgia , Penney Kathryn L. , Mosquera Juan Miguel , Tyekucheva Svitlana , Mucci Lorelei A. , Barbieri Christopher , Loda Massimo
Published: April 2023

Scheme of Sample Selection.
Supplementary Table S3 from Comprehensive Transcriptome and Mutational Profiling of Endemic Burkitt Lymphoma Reveals EBV Type–Specific Differences
Authors: Kaymaz Yasin , Oduor Cliff I. , Yu Hongbo , Otieno Juliana A. , Ong'echa John Michael , Moormann Ann M. , Bailey Jeffrey A.
Published: April 2023

Gene set enrichment results after incorporating the surrogate variable analysis. Significantly enriched GO terms defining the differences between tumor biopsy collection techniques. Significantly enriched KEGG pathways defining the differences between BL subtypes. Significantly enriched KEGG pathways and GO terms defining the differences between EBV positive and negative BLs.
Supplementary Figure 3 from Vasohibin-2 Expressed in Human Serous Ovarian Adenocarcinoma Accelerates Tumor Growth by Promoting Angiogenesis
Authors: Takahashi Yoshifumi , Koyanagi Takahiro , Suzuki Yasuhiro , Saga Yasushi , Kanomata Naoki , Moriya Takuya , Suzuki Mitsuaki , Sato Yasufumi
Published: April 2023

PDF file - 97K, RT-PCR analysis of VASH2 in murine tumorigenic cell lines
Supplementary Figure 4 from Expression of Wnt3 Activates Wnt/β-Catenin Pathway and Promotes EMT-like Phenotype in Trastuzumab-Resistant HER2-Overexpressing Breast Cancer Cells
Authors: Wu Yanyuan , Ginther Charles , Kim Juri , Mosher Nicole , Chung Seyung , Slamon Dennis , Vadgama Jaydutt V.
Published: April 2023

PDF file - 110K, Confirmation of Wnt/beta-catenin signaling pathway genes and protein expression
Supplementary Figure 4 from The ATPase Activity of Reptin Is Required for Its Effects on Tumor Cell Growth and Viability in Hepatocellular Carcinoma
Authors: Grigoletto Aude , Neaud Véronique , Allain-Courtois Nathalie , Lestienne Patrick , Rosenbaum Jean
Published: April 2023

PDF file - 42K, Measurement of Caspase-3 activity.
Supplemental Figure 3 from DNA-Directed Polymerase Subunits Play a Vital Role in Human Telomeric Overhang Processing
Authors: Diotti Raffaella , Kalan Sampada , Matveyenko Anastasiya , Loayza Diego
Published: April 2023

Supplemental Figure 3. A. Extracts prepared from HTC75 cells expressing retrovirally transduced MYC-POLA2 were used for immunoprecipitations with the antibodies indicated at the top of the lanes. PI: preimmune serum, S: immune serum. The Western blot was probed with the anti-MYC 9E10 antibody. B. As in A, in HeLa 1.2.11 cells. C. Extract prepared from HTC75 cells expressing FLAG-TRF1, to show the association between TRF1 and p180 or p68.
Supplementary Table 1 from RhoC Is an Unexpected Target of RhoGDI2 in Prevention of Lung Colonization of Bladder Cancer
Authors: Griner Erin M. , Dancik Garrett M. , Costello James C. , Owens Charles , Guin Sunny , Edwards Michael G. , Brautigan David L. , Theodorescu Dan
Published: April 2023

Supplementary Table 1. Mass spectrometry results of proteins co-immunoprecipatating with RhoGDI2
Supplementary Methods and Materials from miRNA Profiling in Colorectal Cancer Highlights miR-1 Involvement in MET-Dependent Proliferation
Authors: Reid James F. , Sokolova Viktorija , Zoni Eugenio , Lampis Andrea , Pizzamiglio Sara , Bertan Claudia , Zanutto Susanna , Perrone Federica , Camerini Tiziana , Gallino Gianfrancesco , Verderio Paolo , Leo Ermanno , Pilotti Silvana , Gariboldi Manuela , Pierotti Marco A.
Published: April 2023

PDF file - 152K
Supplementary Figure 1 from Anti–IL-20 Monoclonal Antibody Alleviates Inflammation in Oral Cancer and Suppresses Tumor Growth
Authors: Hsu Yu-Hsiang , Wei Chi-Chen , Shieh Dar-Bin , Chan Chien-Hui , Chang Ming-Shi
Published: April 2023

PDF file - 4.4MB, Anti-IL-20 mAb treatment suppressed tumor growth in vivo
Supplementary Methods and Data Figures S1-4 from Targeting Fatty Acid Oxidation to Promote Anoikis and Inhibit Ovarian Cancer Progression
Authors: Sawyer Brandon T. , Qamar Lubna , Yamamoto Tomomi M. , McMellen Alexandra , Watson Zachary L. , Richer Jennifer K. , Behbakht Kian , Schlaepfer Isabel R. , Bitler Benjamin G.
Published: April 2023

Figure S1. HGSOC cells cultured in suspension upregulate Carnitine and Fatty Acid Metabolism. Figure S2. Confirmation of CPT1A antibody specificity. Figure S3. Oxygen consumption rate (OCR) in suspension cells and oleic acid rescue of anoikis. Figure S4. Mouse model design and toxicities.
Supplementary Figure 4 from Synergistic Effect of Olaparib with Combination of Cisplatin on PTEN-Deficient Lung Cancer Cells
Authors: Minami Daisuke , Takigawa Nagio , Takeda Hiromasa , Takata Minoru , Ochi Nobuaki , Ichihara Eiki , Hisamoto Akiko , Hotta Katsuyuki , Tanimoto Mitsune , Kiura Katsuyuki
Published: April 2023

PDF file - 76K, Western blot analysis of cleaved-caspase 3 in H1650, H1650PTEN+, PC-9 and PC-9PTEN- xenografts. The combination of cisplatin with olaparib seemed to have more cleaved-caspase 3 expressions than other treatments in H1650 and PC-9PTEN- xenografts, but not in PC-9 and H1650PTEN+ xenografts.
Supplementary Figure 1 from Synergistic Effect of Olaparib with Combination of Cisplatin on PTEN-Deficient Lung Cancer Cells
Authors: Minami Daisuke , Takigawa Nagio , Takeda Hiromasa , Takata Minoru , Ochi Nobuaki , Ichihara Eiki , Hisamoto Akiko , Hotta Katsuyuki , Tanimoto Mitsune , Kiura Katsuyuki
Published: April 2023

PDF file - 50K, Western blot showing PTEN expression in PC-9, A549, H1299 and PC-3 cells.
Supplementary Table 1 from Nanoscale Tuning of VCAM-1 Determines VLA-4–Dependent Melanoma Cell Plasticity on RGD Motifs
Authors: Amschler Katharina , Kossmann Eugen , Erpenbeck Luise , Kruss Sebastian , Schill Tillmann , Schön Margarete , Möckel Sigrid M.C. , Spatz Joachim P. , Schön Michael P.
Published: April 2023

Primers and conditions used in PCR analysis.
Figure S1 from Mitochondria Participate in Chemoresistance to Cisplatin in Human Ovarian Cancer Cells
Authors: Zampieri Luca X. , Grasso Debora , Bouzin Caroline , Brusa Davide , Rossignol Rodrigue , Sonveaux Pierre
Published: April 2023

Figure S1 shows that, compared to matched cisplatin-sensitive cells, SKOV-3-R cells have higher Complex I activity and COV-362-R cells have better coupled respiration.